Explore the latest insights into the development and regulation of Highly Potent Active Pharmaceutical Ingredients (HPAPIs) in this expert-led on-demand webinar, originally held in May 2025.
This session dives deep into the evolving role of HPAPIs—particularly in oncology and other targeted therapies where precision is critical. As formulation techniques become more complex, the webinar highlights how emerging R&D strategies are enabling the safe, scalable, and compliant production of these powerful compounds.
How HPAPIs deliver therapeutic effects at lower doses, minimizing side effects
The role of HPAPIs in targeted therapies, especially oncology, to improve precision
Current trends in HPAPI R&D, including formulation and process innovations
Approaches to handling safety and containment challenges in manufacturing
How to meet global regulatory expectations for HPAPI development and facilities
Balancing innovation and compliance when scaling HPAPI production
Sankappa Rai, PhD, PMP®
Sr. Director, Technical Operations, Chemical Development and Manufacturing Solutions, Aragen
